IMAN allogeneic neutrophil cell therapy platform
preclinicalplatform · high · Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Develop off-the-shelf Immuno-Modulatory Alpha Neutrophil cell therapies for hard-to-treat solid tumours by exploiting neutrophil tumour-homing, tumour-infiltrating, direct cancer-cell-killing, and immune-modulating attributes.
Allogeneic neutrophil-based cell therapy platform using Immuno-Modulatory Alpha Neutrophils.
Platform is advancing a pipeline across multiple solid cancers, with a first-in-human Phase 1 study planned for advanced cervical and head and neck cancers.